Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Genmab Upgraded to Outperform at William Blair
Incyte Analyst Ratings
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss